Gyeongsang National University Hospital

🇰🇷South Korea
Ownership
Subsidiary
Established
1987-01-01
Employees
-
Market Cap
-
Website
http://www.gnuh.co.kr

Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

First Posted Date
2013-09-26
Last Posted Date
2020-08-20
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
255
Registration Number
NCT01951001
Locations
🇰🇷

Gyeonsang National University Hospital, Jinju, Gyeonsangnam-do,, Korea, Republic of

ACCEL-LOADING-ACS Study

First Posted Date
2011-05-17
Last Posted Date
2013-09-24
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
220
Registration Number
NCT01354808
Locations
🇰🇷

Gyeonsang National University Hospital, Jinju, Gyeonsangnam-do, Korea, Republic of

Methylprednisolone Replacement for Dexamethasone-induced Hiccup

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2011-01-17
Last Posted Date
2012-11-20
Lead Sponsor
Gyeongsang National University Hospital
Registration Number
NCT01277731
Locations
🇰🇷

Gyeongsang University Hospital, Jinju, Korea, Republic of

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

First Posted Date
2010-03-31
Last Posted Date
2011-06-23
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
78
Registration Number
NCT01096745
Locations
🇰🇷

Gyeongsang University Hospital, Jinju, Gyeongsang Namdo, Korea, Republic of

Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism

First Posted Date
2009-11-11
Last Posted Date
2011-05-17
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
134
Registration Number
NCT01012193
Locations
🇰🇷

Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, Korea, Republic of

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-10-15
Last Posted Date
2014-03-03
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
48
Registration Number
NCT00995761
Locations
🇰🇷

Gyeongsang National University Hospital, Jinju, Gyeongsang-Nam-Do, Korea, Republic of

Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

First Posted Date
2009-06-17
Last Posted Date
2012-11-20
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
22
Registration Number
NCT00922896
Locations
🇰🇷

Gyeongsang Unversity Hospital, JinJU, Korea, Republic of

🇰🇷

Dong-A University Hospital, Busan, Korea, Republic of

🇰🇷

Chung-Ang University Hospital, Seoul, Korea, Republic of

Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism

First Posted Date
2009-06-08
Last Posted Date
2009-11-10
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
80
Registration Number
NCT00915733
Locations
🇰🇷

Gyeongsang National University Hospital, Jinju, Korea, Republic of

Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism

First Posted Date
2009-05-01
Last Posted Date
2009-05-01
Lead Sponsor
Gyeongsang National University Hospital
Target Recruit Count
80
Registration Number
NCT00891670
Locations
🇰🇷

Gyeong-Sang National University Hospital, Jinju, Gyeong-Nam, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath